Logo image of ASPS

ALTISOURCE PORTFOLIO SOL (ASPS) Stock Fundamental Analysis

NASDAQ:ASPS - Nasdaq - LU0445408270 - Common Stock - Currency: USD

0.7301  -0.05 (-6.4%)

After market: 0.7404 +0.01 (+1.41%)

Fundamental Rating

1

Taking everything into account, ASPS scores 1 out of 10 in our fundamental rating. ASPS was compared to 64 industry peers in the Real Estate Management & Development industry. Both the profitability and financial health of ASPS have multiple concerns. ASPS is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ASPS has reported negative net income.
In the past year ASPS has reported a negative cash flow from operations.
In the past 5 years ASPS reported 4 times negative net income.
ASPS had negative operating cash flow in 4 of the past 5 years.
ASPS Yearly Net Income VS EBIT VS OCF VS FCFASPS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M

1.2 Ratios

With a Return On Assets value of -27.69%, ASPS is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -27.69%
ROE N/A
ROIC N/A
ROA(3y)-19.71%
ROA(5y)-32.51%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ASPS Yearly ROA, ROE, ROICASPS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500 1K

1.3 Margins

ASPS has a Gross Margin (29.70%) which is comparable to the rest of the industry.
ASPS's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for ASPS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 29.7%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.34%
GM growth 5Y-4.53%
ASPS Yearly Profit, Operating, Gross MarginsASPS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40

More info and screens

0

2. Health

2.1 Basic Checks

ASPS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ASPS has more shares outstanding
The number of shares outstanding for ASPS has been increased compared to 5 years ago.
Compared to 1 year ago, ASPS has a worse debt to assets ratio.
ASPS Yearly Shares OutstandingASPS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M
ASPS Yearly Total Debt VS Total AssetsASPS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

2.2 Solvency

Based on the Altman-Z score of -3.08, we must say that ASPS is in the distress zone and has some risk of bankruptcy.
ASPS's Altman-Z score of -3.08 is on the low side compared to the rest of the industry. ASPS is outperformed by 85.00% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -3.08
ROIC/WACCN/A
WACC8.35%
ASPS Yearly LT Debt VS Equity VS FCFASPS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M

2.3 Liquidity

ASPS has a Current Ratio of 0.19. This is a bad value and indicates that ASPS is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.19, ASPS is doing worse than 95.00% of the companies in the same industry.
ASPS has a Quick Ratio of 0.19. This is a bad value and indicates that ASPS is not financially healthy enough and could expect problems in meeting its short term obligations.
ASPS's Quick ratio of 0.19 is on the low side compared to the rest of the industry. ASPS is outperformed by 95.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.19
Quick Ratio 0.19
ASPS Yearly Current Assets VS Current LiabilitesASPS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 36.61% over the past year.
Looking at the last year, ASPS shows a small growth in Revenue. The Revenue has grown by 5.19% in the last year.
ASPS shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -29.59% yearly.
EPS 1Y (TTM)36.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%35.29%
Revenue 1Y (TTM)5.19%
Revenue growth 3Y-26.51%
Revenue growth 5Y-29.59%
Sales Q2Q%-30.97%

3.2 Future

Based on estimates for the next years, ASPS will show a very strong growth in Earnings Per Share. The EPS will grow by 34.72% on average per year.
The Revenue is expected to grow by 21.42% on average over the next years. This is a very strong growth
EPS Next Y48.55%
EPS Next 2Y34.72%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year10.15%
Revenue Next 2Y21.42%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ASPS Yearly Revenue VS EstimatesASPS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
ASPS Yearly EPS VS EstimatesASPS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2 -2 4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ASPS. In the last year negative earnings were reported.
Also next year ASPS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ASPS Price Earnings VS Forward Price EarningsASPS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

61.67% of the companies in the same industry are more expensive than ASPS, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 35.49
ASPS Per share dataASPS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5

4.3 Compensation for Growth

ASPS's earnings are expected to grow with 34.72% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.72%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ASPS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ALTISOURCE PORTFOLIO SOL

NASDAQ:ASPS (2/20/2025, 8:00:00 PM)

After market: 0.7404 +0.01 (+1.41%)

0.7301

-0.05 (-6.4%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)10-24 2024-10-24/bmo
Earnings (Next)03-06 2025-03-06/bmo
Inst Owners33.99%
Inst Owner Change4.43%
Ins Owners33.79%
Ins Owner Change10.24%
Market Cap19.88M
Analysts43.33
Price Target10.2 (1297.07%)
Short Float %4.61%
Short Ratio3.81
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-25.43%
Min EPS beat(2)-34.8%
Max EPS beat(2)-16.05%
EPS beat(4)1
Avg EPS beat(4)-10.56%
Min EPS beat(4)-34.8%
Max EPS beat(4)17.04%
EPS beat(8)4
Avg EPS beat(8)-4.34%
EPS beat(12)5
Avg EPS beat(12)-5.51%
EPS beat(16)5
Avg EPS beat(16)-24.67%
Revenue beat(2)0
Avg Revenue beat(2)-24.52%
Min Revenue beat(2)-46.46%
Max Revenue beat(2)-2.57%
Revenue beat(4)1
Avg Revenue beat(4)-11.57%
Min Revenue beat(4)-46.46%
Max Revenue beat(4)10.63%
Revenue beat(8)3
Avg Revenue beat(8)-6.04%
Revenue beat(12)4
Avg Revenue beat(12)-5.32%
Revenue beat(16)5
Avg Revenue beat(16)-6.35%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-25.93%
EPS NQ rev (3m)-25.93%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-4.02%
Revenue NQ rev (3m)-4.02%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.11%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.13
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 35.49
EPS(TTM)-1.42
EYN/A
EPS(NY)-0.42
Fwd EYN/A
FCF(TTM)-0.29
FCFYN/A
OCF(TTM)-0.29
OCFYN/A
SpS5.63
BVpS-5.49
TBVpS-8.38
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -27.69%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 29.7%
FCFM N/A
ROA(3y)-19.71%
ROA(5y)-32.51%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.34%
GM growth 5Y-4.53%
F-Score6
Asset Turnover1.06
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 0.04
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.19
Quick Ratio 0.19
Altman-Z -3.08
F-Score6
WACC8.35%
ROIC/WACCN/A
Cap/Depr(3y)6.63%
Cap/Depr(5y)6.97%
Cap/Sales(3y)0.45%
Cap/Sales(5y)0.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)36.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%35.29%
EPS Next Y48.55%
EPS Next 2Y34.72%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.19%
Revenue growth 3Y-26.51%
Revenue growth 5Y-29.59%
Sales Q2Q%-30.97%
Revenue Next Year10.15%
Revenue Next 2Y21.42%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y98.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year191.73%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y85.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y84.75%
OCF growth 3YN/A
OCF growth 5YN/A